Clinical Guide for Myeloid Molecular Testing with Rapid NGS

Next-generation sequencing (NGS) provides tremendous benefits for molecular testing of myeloid malignancies. With an ever-growing list of biomarkers, inherent genetic complexity, and the risk of rapid progression, myeloid malignancies challenge the current iterative testing paradigm and call for a streamlined testing approach that yields rapid results. 

Discover the benefits of our complimentary resource:

• Comprehensive Insights—understand the latest blood cancer diagnostic landscape and technology
• Molecular testing evolution—discover how rapid in-house NGS testing can enhance profiling for AML, MDS, and MPN
• Expert perspectives—get comparative insights and learn from top experts on effective testing methods
• Clinical guidelines—stay up to date with WHO and ELN guidelines for risk stratification and recurrence monitoring

Empower your practice with cutting-edge NGS advancements. Download your free e-book today. If you would like a representative to contact you to discuss NGS testing for myeloid malignancies for your lab, you may select that option in the form.